Scarica l'app Stockscreener
5.43
2.65%
0.14
Dopo l'orario di chiusura:
5.47
0.04
+0.74%
Precedente Chiudi:
$5.29
Aprire:
$5.36
Volume 24 ore:
612.87K
Relative Volume:
0.74
Capitalizzazione di mercato:
$298.08M
Reddito:
$124.00K
Utile/perdita netta:
$-49.99M
Rapporto P/E:
-3.213
EPS:
-1.69
Flusso di cassa netto:
$-31.03M
1 W Prestazione:
+12.19%
1M Prestazione:
-8.74%
6M Prestazione:
-37.30%
1 anno Prestazione:
-22.76%
Intervallo 1D:
$5.27
$5.485
Intervallo di 1 settimana:
$4.80
$5.49
Portata 52W:
$3.785
$14.60
Candel Therapeutics Inc Stock (CADL) Company Profile
Nome
Candel Therapeutics Inc
Settore
Industria
Telefono
617-916-5445
Indirizzo
117 KENDRICK STREET, NEEDHAM
Confronta CADL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CADL
Candel Therapeutics Inc
|
5.43 | 290.40M | 124.00K | -49.99M | -31.03M | -1.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-06-30 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-20 | Iniziato | Citigroup | Buy |
| 2025-02-19 | Iniziato | Canaccord Genuity | Buy |
| 2025-02-07 | Iniziato | BofA Securities | Buy |
| 2022-12-02 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Outperform |
| 2021-08-23 | Iniziato | Credit Suisse | Outperform |
| 2021-08-23 | Iniziato | Jefferies | Buy |
| 2021-08-23 | Iniziato | UBS | Buy |
Mostra tutto
Candel Therapeutics Inc Borsa (CADL) Ultime notizie
Candel Therapeutics, Inc. (NASDAQ:CADL) Given Average Rating of "Buy" by Analysts - MarketBeat
Candel Therapeutics, Inc. $CADL Shares Purchased by Halter Ferguson Financial Inc. - MarketBeat
Candel Therapeutics (NASDAQ:CADL) Rating Increased to Hold at Wall Street Zen - MarketBeat
Candel Therapeutics Inc. stock volume spike explainedGap Up & Safe Entry Trade Signal Reports - newser.com
Aug Setups: Should I hold or sell Candel Therapeutics Inc nowJuly 2025 Weekly Recap & Technical Pattern Based Signals - khodrobank.com
Aug Setups: Can Candel Therapeutics Inc beat the S P 500Market Rally & Low Risk Growth Stock Ideas - خودرو بانک
Should you hold or exit Candel Therapeutics Inc. nowJuly 2025 Institutional & Real-Time Stock Movement Alerts - newser.com
Using Python tools to backtest Candel Therapeutics Inc. strategiesJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com
Is now a turning point for Candel Therapeutics Inc.Portfolio Update Report & Free Daily Entry Point Trade Alerts - newser.com
Is Candel Therapeutics Inc. stock bottoming outWeekly Risk Report & AI Powered Market Entry Strategies - newser.com
Analyzing Candel Therapeutics Inc. with risk reward ratio chartsPortfolio Value Summary & Daily Stock Trend Watchlist - newser.com
New Highs: Will Candel Therapeutics Inc face regulatory challengesJobs Report & Scalable Portfolio Growth Ideas - خودرو بانک
Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025 - GlobeNewswire
Ranking Candel Therapeutics Inc. among high performing stocks via toolsShare Buyback & AI Powered Market Trend Analysis - newser.com
Candel Therapeutics to present Phase 3 CAN-2409 data at ASTRO 2025 - Proactive financial news
H.C. Wainwright Maintains Candel Therapeutics(CADL.US) With Buy Rating, Maintains Target Price $23 - 富途牛牛
Candel Therapeutics, Inc. Announces Oral Presentation of CAN-2409 Data at 2025 ASTRO Annual Meeting - Quiver Quantitative
Major Phase 3 Prostate Cancer Treatment Results: Candel's CAN-2409 Data Coming to ASTRO Conference - Stock Titan
S P Trends: Will Candel Therapeutics Inc face regulatory challengesMarket Rally & Accurate Entry/Exit Alerts - خودرو بانک
Aug Sentiment: Can Candel Therapeutics Inc. expand its profit marginsPortfolio Value Report & Weekly High Conviction Trade Ideas - خودرو بانک
Published on: 2025-09-17 04:59:57 - khodrobank.com
Aug Momentum: What is Candel Therapeutics Inc.’s valuation compared to sector2025 Major Catalysts & Safe Entry Zone Identification - خودرو بانک
Aug Mood: Is Candel Therapeutics Inc stock forming a triangle pattern2025 Trade Ideas & AI Forecast Swing Trade Picks - khodrobank.com
Trend Review: What are Candel Therapeutics Inc.’s earnings expectationsWeekly Loss Report & Expert Approved Momentum Ideas - خودرو بانک
Sentiment Recap: Can Candel Therapeutics Inc. beat the S&P 500Market Performance Report & Safe Entry Point Identification - خودرو بانک
Acorn Capital Advisors LLC Has $12.16 Million Stock Holdings in Candel Therapeutics, Inc. $CADL - MarketBeat
Candel Therapeutics Inc. stock trendline breakdownWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com
Candel Therapeutics (NASDAQ:CADL) Stock Rating Lowered by Wall Street Zen - MarketBeat
Nuveen LLC Makes New $442,000 Investment in Candel Therapeutics, Inc. $CADL - MarketBeat
Candel Therapeutics (NASDAQ:CADL) Lowered to Neutral Rating by Bank of America - MarketBeat
Candel Therapeutics: Potentially The Next Exciting Oncology Story - Seeking Alpha
Baker BROS. Advisors LP Cuts Holdings in Candel Therapeutics, Inc. $CADL - MarketBeat
Can Candel Therapeutics Inc. be recession proofQuarterly Performance Summary & Weekly Setup with ROI Potential - 뉴스영
What MACD and RSI say about Candel Therapeutics Inc.July 2025 Earnings & Low Risk Entry Point Guides - Newser
How volatile is Candel Therapeutics Inc. stockWeekly Market Outlook & Smart Allocation Stock Tips - 더경남뉴스
Can Candel Therapeutics Inc. expand its profit marginsWeekly Trend Report & Real-Time Market Sentiment Alerts - خودرو بانک
What is Candel Therapeutics Inc.’s valuation compared to sectorEarnings Recap Report & Real-Time Volume Surge Alerts - خودرو بانک
Dow Update: Is Candel Therapeutics Inc. benefiting from interest rate changesTake Profit & Verified Technical Signals - خودرو بانک
Will Candel Therapeutics Inc. benefit from macro trendsWeekly Trade Summary & Reliable Intraday Trade Plans - Newser
Pattern recognition hints at Candel Therapeutics Inc. upsideTrade Volume Summary & Precise Buy Zone Identification - Newser
Insider Purchases Worth US$3.00m See Losses As Candel Therapeutics Market Value Drops To US$280m - 富途牛牛
Advanced analytics toolkit walkthrough for Candel Therapeutics Inc.2025 Market Outlook & Weekly High Momentum Picks - Newser
Should I average down on Candel Therapeutics Inc. stockRate Cut & Free Real-Time Market Sentiment Alerts - خودرو بانک
Candel Therapeutics: Revolutionizing Solid Tumor Treatment with Viral Immunotherapies - AInvest
Candel Therapeutics: Oncolytic Immunotherapy Showing Broad Efficacy In Tough Tumors - Seeking Alpha
What are Candel Therapeutics Inc.’s earnings expectationsPortfolio Performance Summary & Free Verified High Yield Trade Plans - خودرو بانک
How to track smart money flows in Candel Therapeutics Inc.Share Buyback & Consistent Return Strategy Ideas - Newser
Chart based analysis of Candel Therapeutics Inc. trendsJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser
Candel Therapeutics Inc. stock daily chart insights2025 Market Overview & Long-Term Growth Portfolio Plans - Newser
Candel Therapeutics Inc Azioni (CADL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.30%
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):